We represent North American and European companies in India.
We facilitate sales of API’s, intermediates, excipients, finished formulations to Indian MNC’S
Our services to these companies include end to end solutions. This encompasses liaison, introduction of the company and its product line in the Indian market, registration, support in compiling ANDA / EU Dossiers. We eventually manage the execution of orders and client relationship.
We have successfully registered several API’s with the DCGI in India.
Polpharma Group is a high quality European Pharma and biotech manufacturer and a reputable business partner for pharmaceutical companies worldwide. They grow their presence through B2B activities, including API custom development and manufacturing in their cGMP-compliant and FDA-approved facility, out-licensing of vertically integrated solutions from API to finished formulation, and contract manufacturing services covering a wide variety of solid and liquid forms. They are also a fully integrated, state-of-the-art biotechnology player mastering all steps of the cell culture value chain from cell line via process and product development to GMP manufacturing up to commercial scale, applying this to own biosimilars and contract-manufacturing.
The Uquifa group is a cGMP producer of Active Pharmaceutical Ingredients (APIs) and intermediates. The group operates 3 FDA inspected plants in Spain (2) and Mexico. With approximately 600,000 litres of reactor capacity, a complete range of chemical capabilities are available and include hydrogenation, chlorination, micronization and so forth. Highly qualified R&D teams and versatile pilot plants are available for product development, scale-up and commercialization, in addition to supplying API to the Generics Industry. Custom synthesis is conducted with the highest degree of confidentiality. Products - supplied to more than 500 companies in more than 60 countries globally- cover a wide range of therapeutic categories.
For decades Polymed Therapeutics has been a leading global manufacturer and distributor of Active Pharmaceutical Ingredients (cGMP API). They are committed to the highest quality products, at the most competitive pricing. Headquartered in USA, Polymed has several state-of-the-art GMP manufacturing facilities and R&D laboratories in China. Their API facility is GMP APPROVED by FDA, EU and JAPAN ! Their APIs are used in ANDA/NDA approved drugs in US, EU, Asia & MENA. Pharmaceutical grade APIs include: DOCETAXEL, CABAZITAXEL, PACITAXEL, Irinotecan, Oxaliplatin, Azacytidine, Bortezomib, Decitabine, Cholecalciferol (Vit D3), Ergocalciferol (Vit D2), Vit D Analogs: Doxercalciferol, Calcitriol, Paricalcitol, plus Pharma Grade Sucralose.
Angelini Pharma has a cGMP facility, inspected by US FDA since 1979, and by all international regulatory aothorities. Speciaized in Custom synthesis of API's and Advanced Intermediated, equipped with a Class C (10,000) kilo lab and four production units. Angelini Fine Chemicals Plants is specialized in Costum's Synthesis of API's and Advanced Intermediates. It has 140.000 Lt gasslined and Stainless steel Reactor Capacity and a Pilot plant with 250 -800 Lt reactor capacity. Multipurpose technology base, full analytical services and support, blending and sieving. Flow Reactors allowing new syntheses heretofore not possible, increase yields, product quality, scalability and efficiency of Chemical processing, reducing the performance variability and costs. Leader in the wellness industry, a point of reference in the field of health protection, Angelini is the natural choice for daily wellbeing. Angelini manufactures, markets and distributes products for personal health and wellbeing. Angelini is an "integrated company" with extensive research
Uriach is a family-run pharmaceutical company that is dedicated to improving the health, wellbeing and quality of life of people all over the world. The company has their two main business areas: Consumer Healthcare (OTC and Natural Care) and Business to Business (including NCEs, Generics and Contract Manufacturing). Present in Spain, Italy and Portugal, Uriach is currently in a period of international expansion with its products being sold in more than 70 countries. Founded in 1838, the company has always maintained a profitable, sustainable business model. Uriach currently employs 700 staff at two chemical and pharmaceutical production plants in the Barcelona area in which it produces its own products and also manufactures for third parties. Uriach's turnover in the 2016 financial year was 151 million euro, of which 60% sales were outside the domestic market.
Umicore Precious Metals Chemistry strengths are a combination of customer orientation, process excellence, innovation leadership and diversity. Their customer focused technology platforms align worldwide all necessary resources from Research & Development to Marketing & Sales through Production, providing expertise in transition metals chemistry, high potency APIs, catalysts and high purity chemicals manufacturing, and related applications. It offers first class products and services allowing customers to use metal based technologies in the most effective and sustainable way. Umicore PMC's advanced chemicals and catalysts are mostly used in the industrial synthesis of active pharmaceutical ingredients, polymers, automotive catalytic converters or electronic materials. Products: Active Pharmaceutical Ingredients, Exclusive Synthesis of APIs, Homogeneous Catalysts, Pharmaceutical Intermediates
Urquima : Urquima belongs to the Uriach group. They are involved in the fine chemical activities of the company providing both first-kilo and industrial quantities of Uriach's active principles.
Flavine: Flavine International, Inc. has been developing markets for fine chemicals and active pharmaceutical ingredients for over 26 years. Flavine's customers are in the Human and Animal Health industries and Flavine's manufacturers supply them APIs, Intermediates, Nutritional Supplements, and Phyto-Pharmaceuticals from around the world. Products commercially marketed by Flavine meet all North American and European Regulatory Standards.
Zhejiang Hisun Chemical Co., Ltd (hereafter called as ”Hisun Chemical), founded in 1998, is a state-holding enterprise invested by State Development & Investment Corporation(SDIC), Zhejiang Hisun Group and ZMC Co., Ltd. The company now covers an area of 312,000 square meters and 35‰ of its staff members are technicians.
With its total assets of nearly USD 60 million, Hisun Chemical has created a niche in agrochemical field through its sustainable researching, marketing efforts and strong distribution network. The company, with its headquarter located in Taizhou, Zhejiang, now has two wholly-owned subsidiary companies , two Sino-foreign joint ventures and one Provincial Hi-tech R&D Centre.
Apothecon is a research based pharmaceutical company located at Vadodara, in Gujarat State of India. They conduct research and development for their own and to support their global business partners in development of quality products. Company adhere national and international GMP guidance for Designing, Developing, Maintaining Facility, Processes and Products. The site is US FDA & MHRA inspected facility registered with US FDA and certified for complying GMP by FDCA Gujarat, India and WHO.
GSK: GlaxoSmithKline (GSK) is a British pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company.